Navigation Links
AMERIGROUP Praises Expansion of State Children's Health Insurance Program (SCHIP)
Date:2/5/2009

VIRGINIA BEACH, Va., Feb. 5, 2009 /PRNewswire-FirstCall/ -- AMERIGROUP Chairman and Chief Executive Officer James G. Carlson released the following statement on legislation expanding the State Children's Health Insurance Program (SCHIP), which was signed yesterday by President Barack Obama:

"All of America's children deserve a healthy start in life, and that happens only when they are able to see a family doctor and get the healthcare they need. President Obama and Congress have taken a major step toward achieving this goal by approving legislation that expands the State Children's Health Insurance Program (SCHIP).

"SCHIP ensures that the children of lower-income working families are not denied the right to see a doctor or visit a hospital when they are sick. This not only makes a difference in the lives of our children, but by enabling them to stay healthy it saves money for taxpayers in the long run. Under the legislation signed into law yesterday, SCHIP will now cover 11 million of our nation's young people, up from 7 million. This is both the right thing to do and the smart thing do.

"At AMERIGROUP, we see the human impact of SCHIP every day. We bring healthcare to about 279,000 children enrolled in SCHIP -- about one out of every 25 kids in the program. We know that SCHIP is a lifeline for America's children. And we are pleased that this legislation will enable millions more of them to get the healthy start they deserve."

About AMERIGROUP Corporation

AMERIGROUP Corporation, headquartered in Virginia Beach, Virginia, improves healthcare access and quality for the financially vulnerable, seniors and people with disabilities by developing innovative managed health services for the public sector. Through its subsidiaries, AMERIGROUP Corporation serves approximately 1.6 million people in Florida, Georgia, Maryland, Nevada, New Jersey, New Mexico, New York, Ohio, South Carolina, Tennessee, Texas and Virginia. For more information, visit www.amerigroupcorp.com.

    CONTACTS:
    Investors:  Julie Loftus Trudell
                AMERIGROUP Corporation
                Senior Vice President, Investor Relations
                (757) 321-3597

    News Media:  Kent Jenkins, Jr.
                 AMERIGROUP Corporation
                 Senior Vice President, Media Relations
                 (757) 769-7859


'/>"/>
SOURCE AMERIGROUP Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AMERIGROUP Corporation Named One of Best Places to Work in Healthcare
2. AMERIGROUP Corporation to Discuss Third Quarter Earnings on October 23
3. AMERIGROUP Reaches Agreement in Principle to Settle Illinois Qui Tam Litigation
4. AMERIGROUP Corporation to Present at the CIBC World Markets 18th Annual Healthcare Conference on November 5
5. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
6. New General Manager, Transition to New Raleigh Offices Highlight Datatrials Expansion of North American Operations
7. ScienceFirst Staff Expansion
8. Cell Therapeutics Targeting Potential Zevalin Label Expansion, Pixantrone and OPAXIO Drug Approvals to Grow Commercial Operations and Revenues in 2009
9. Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
10. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
11. N30 Pharma Announces Financing, Expansion of Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... (PRWEB) , ... April 20, 2017 , ... Parallel6™ ... clinical trials worldwide, announced today that they were named one of the 2017 ... covers the latest developments in the pharmaceutical industry. , “We take pride in honoring ...
(Date:4/20/2017)... For today, Stock-Callers.com redirects investors, attention to Biotechnology, ... research aimed at treating diseases and medical conditions. Under evaluation ... (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: KITE), and ZIOPHARM Oncology ... complimentary research reports on these stocks now at: ... http://stock-callers.com/registration Biostage ...
(Date:4/19/2017)... ... April 18, 2017 , ... Optofluidics today announced that ... after the company changed focus to making analytical tools for biopharmaceutical quality control. ... technology,” says CEO Robert Hart. Founders Bernardo Cordovez, Robert Hart and David Erickson ...
(Date:4/19/2017)... ... April 19, 2017 , ... As part of ... accessible to novices as well as experienced users, attendees will gain a better ... screening tests. , Hemostasis testing quality is determined by preanalytical variables which ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
(Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
Breaking Biology News(10 mins):